newsfilter
← Latest News
GlobeNewswire·

Galecto Reports Second Quarter Operating and Financial Results

BOSTON, July 29, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ:GLTO), a clinical stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today announced its operating and financial results for the quarter en